ArticleBreast cancer research and treatment2014

Risk of cardiovascular adverse events from trastuzumab (Herceptin(®)) in elderly persons with breast cancer: a population-based study.

H-T Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.